<DOC>
	<DOCNO>NCT00336102</DOCNO>
	<brief_summary>RATIONALE : Learning thyroid dysfunction patient breast cancer may help plan treatment may help patient live comfortably . PURPOSE : This clinical trial study often thyroid dysfunction happen woman newly diagnose stage I , stage II , stage III breast cancer plan undergo chemotherapy compare often happen healthy volunteer .</brief_summary>
	<brief_title>Thyroid Dysfunction Women With Newly Diagnosed Breast Cancer Compared Healthy Volunteers</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare proportion hypothyroidism woman newly diagnose stage I-IIIB breast cancer ( prior chemotherapy ) v cancer-free , age-matched healthy volunteer . - Compare magnitude change thyroid function patient baseline 24 month v cancer-free , age-matched healthy volunteer . Secondary - Correlate variation thyroid function fatigue symptom score . - Correlate variation thyroid function anthropometric measurement . OUTLINE : This pilot , multicenter study . Patients age-matched healthy volunteer undergo blood collection baseline 12 24 month enrollment . They also undergo anthropometric measurement complete Fatigue Symptom Inventory baseline 12 24 month enrollment . PROJECTED ACCRUAL : A total 270 patient 280 healthy volunteer accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Hypothyroidism</mesh_term>
	<criteria>CASE SELECTION : CASE INCLUSION CRITERIA : Women age 25 75 Diagnosed primary operable Stage I IIIB breast cancer Scheduled receive neoadjuvant adjuvant Adriamycin Cytoxan ( AC ) plus taxane ( taxane may give AC follow AC ) No chemotherapy prior baseline sample collection No prior history cancer ( except nonmelanoma skin cancer ) Preoperative radiation therapy permit No diagnosis hypothyroidism hyperthyroidism . CASE EXCLUSION CRITERIA : Stage IV breast cancer Scheduled receive neoadjuvant hormonal therapy ( patient receive adjuvant hormonal therapy may participate ) Received adjuvant hormonal therapy chemotherapy prior sample collection On chemotherapeutic regimen Adriamycin Cytoxan plus taxane . Patients receive monoclonal antibody biologic therapy may participate Patients schedule receive Herceptin may participate Diagnosed hyperthyroidism hypothyroidism . ( Women treat hypothyroidism eligible ) Women baseline TSH 10 high continue study Women pregnant lactate eligible . ( Women childbearing potential planning become pregnant within next 24 month enroll study ) CONTROL SELECTION : CONTROL INCLUSION CRITERIA : Can blood relative case . They friends , neighbor , woman social activity , local business , doctor ' office , etc . Must live near town case Women age 20 80 ( agematched case +/ 5 year ) No prior history cancer ( except nonmelanoma skin cancer ) Women age 40 old mammogram within 2 year study entry , show evidence breast cancer . The friend control may bring mammogram report send release record fax enrol center . Women age 40 clinical breast examination within 2 year study entry , show need diagnostic mammography . If mammogram require , show evidence breast cancer . The friend control may bring mammogram / breast exam report send release record fax enrol center .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>fatigue</keyword>
	<keyword>hypothyroidism</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
</DOC>